Prosecution Insights
Last updated: July 17, 2026
Application No. 18/956,401

SYSTEM AND METHOD FOR PREPARING BONE

Final Rejection §103
Filed
Nov 22, 2024
Priority
Feb 24, 2009 — provisional 61/208,451 +5 more
Examiner
KU, SI MING
Art Unit
3775
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Mako Surgical Corp.
OA Round
2 (Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
1y 5m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
558 granted / 768 resolved
+2.7% vs TC avg
Strong +33% interview lift
Without
With
+32.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
35 currently pending
Career history
812
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
56.9%
+16.9% vs TC avg
§102
27.1%
-12.9% vs TC avg
§112
4.9%
-35.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 768 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Status of the Claims This Office Action is responsive to the amendment filed March 17, 2026. As directed by the amendment: Claims 10-15 have been amended. Claims 1-20 are presently pending in this application. Claim Rejections - 35 USC § 103 The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 10 and 12-15 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Lang et al. (US 2007/0100462), herein referred to as Lang, and in view of Kang et al. (US 2007/0270685), herein referred to as Kang. Regarding claim 10, Lang discloses a surgical system (¶6), a first bone segment (figure 2Q), a first bone mating structure (figure 2Q), wherein the first bone mating structure (figure 2Q) is curved along its length (figures 2N1 and 2Q) to engage a first portion of a structure (220) (figures 2P and 2Q). Yet, Lang lacks a detailed description on a robotic device configured to assist modification of a bone, and a control system programmed to perform operations comprising controlling the robotic device to guide a cutting tool to sculpt a first bone segment of the bone. However, Kang teaches a robotic device (10, 30) (¶37) configured to (i.e. capable of) assist modification of a bone (¶36), and a control system (CAS, ¶37) programmed to perform operations comprising controlling the robotic device (10, 30) to guide a cutting tool (50) to sculpt a first bone segment of the bone (considered as a first portion of the bone) (¶36). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to provide Lang’s surgical system with a robotic device configured to assist modification of a bone, and a control system programmed to perform operations comprising controlling the robotic device to guide a cutting tool to sculpt a first bone segment of the bone as taught by Kang, since such guidance from a haptic device coupled with computer aided surgery enables a surgeon to actively and accurately control surgical actions, such as bone cutting (¶37). Regarding claim 12, the modified Lang’s surgical system has wherein the first bone mating structure (figure 2Q of Lang) is positioned at (defined as “in, on, or near” by Dicitonary.com) an edge of a bone (figure 2Q of Lang). Regarding claim 13, the modified Lang’s surgical system has wherein the first bone mating structure (figure 2Q of Lang) includes a u-shaped curved channel (figures 2N1 and 2Q of Lang). Regarding claim 14, the modified Lang’s surgical system has wherein the first portion of the structure (220 of Lang) is a first projection (figures 2P and 2Q of Lang). Regarding claim 15, the modified Lang’s surgical system has wherein the operations further comprise guiding alignment of the structure (220 of Lang) with the first bone segment (figure 2Q of Lang) by guiding alignment of a first structure mating surface (220 of Lang) with the first bone mating structure (figure 2Q of Lang). Claim 11 is rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Lang and Kang as applied to claim 10 above, and further in view of Rhodes et al. (US 2007/0299532), herein referred to as Rhodes. Regarding claim 11, the modified Lang’s surgical system discloses all the features/elements as claimed including wherein the first bone mating structure is a first curved channel (figures 2N1 and 2Q of Lang). Yet, the modified Lang’s surgical system lacks wherein the first curved channel is separated from a second curved channel by a region comprising a bone material. However, Rhodes teaches a first curved channel (850) (figure 16) is separated from a second curved channel (880) (figure 16) by a region comprising a bone material (22) (figure 16). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the modified Lang’s surgical system with wherein the first curved channel is separated from a second curved channel by a region comprising a bone material as taught by Rhodes, since such a modification would provide an additional channel to receive a second portion of a structure. Furthermore, it is known that a mere duplication of the essential working parts of a device involves only routine skill in the art. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-17 of U.S. Patent No. 12,193,767 in view of Kang et al. (US 2007/0270685). USP '767 discloses all the features/elements as claimed but lacks providing the second bone segment with a second bone mating surface by sculpting the second bone segment. However, Kang teaches providing a second bone segment (considered as a second portion of the bone) with a second bone mating surface by sculpting the second bone segment (136). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to provide the USP with the second bone segment with a second bone mating surface by sculpting the second bone segment as taught by Kang, since such a modification would allow additional bone segments to be sculpted. Response to Arguments Applicant's arguments filed March 17, 2026 have been fully considered. Applicant’s arguments, see Remarks, filed March 17, 2026, with respect to the rejection(s) of claim(s) 1 and 16 under 35 U.S.C. 103(a) have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, the double patenting rejection has been maintained. Applicant’s arguments with respect to claims 10-15 are directed to the amended claims. Thus, the Examiner has relied upon the combination of references to teach applicant’s amended features, see Office Action above. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SI MING KU whose telephone number is (571)270-5450. The examiner can normally be reached Monday-Friday, 9:30am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Truong can be reached at (571)272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SI MING KU/Primary Examiner, Art Unit 3775
Read full office action

Prosecution Timeline

Nov 22, 2024
Application Filed
Jan 08, 2026
Non-Final Rejection mailed — §103
Feb 10, 2026
Interview Requested
Feb 24, 2026
Examiner Interview Summary
Feb 24, 2026
Applicant Interview (Telephonic)
Mar 17, 2026
Response Filed
Jun 03, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678207
FRACTURE PLATING SYSTEMS
2y 8m to grant Granted Jul 14, 2026
Patent 12678299
ACETABULAR CUP REMOVAL DEVICE FOR ARTIFICIAL HIP JOINTS
1y 7m to grant Granted Jul 14, 2026
Patent 12667400
Intermaxillary Fixation Device And Method Of Using Same
1y 7m to grant Granted Jun 30, 2026
Patent 12661099
Arm Attachment For Retractor And Retractor Blades
3y 2m to grant Granted Jun 23, 2026
Patent 12661164
BONE FIXATION DEVICE
2y 1m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+32.8%)
3y 1m (~1y 5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 768 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month